608 related articles for article (PubMed ID: 34119900)
21. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
Kim YJ; Lee DJ; Park CK; Kim IA
Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
23. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
24. Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study.
Yahanda AT; Patel B; Shah AS; Cahill DP; Sutherland G; Honeycutt J; Jensen RL; Rich KM; Dowling JL; Limbrick DD; Dacey RG; Kim AH; Leuthardt EC; Dunn GP; Zipfel GJ; Leonard JR; Smyth MD; Shah MV; Abram SR; Evans J; Chicoine MR
Neurosurgery; 2020 Dec; 88(1):63-73. PubMed ID: 32717067
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
26. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
[TBL] [Abstract][Full Text] [Related]
28. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
[TBL] [Abstract][Full Text] [Related]
29. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
30. To resect or not to resect? Risks and benefits of surgery in older patients with glioblastoma.
Ahmadipour Y; Rauschenbach L; Gembruch O; Darkwah Oppong M; Michel A; Pierscianek D; Stuschke M; Glas M; Sure U; Jabbarli R
J Geriatr Oncol; 2020 May; 11(4):688-693. PubMed ID: 31672557
[TBL] [Abstract][Full Text] [Related]
31. Role of
Brandes AA; Franceschi E; Paccapelo A; Tallini G; De Biase D; Ghimenton C; Danieli D; Zunarelli E; Lanza G; Silini EM; Sturiale C; Volpin L; Servadei F; Talacchi A; Fioravanti A; Pia Foschini M; Bartolini S; Pession A; Ermani M
Oncologist; 2017 Apr; 22(4):432-437. PubMed ID: 28275120
[TBL] [Abstract][Full Text] [Related]
32. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
33. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
Jiang H; Cui Y; Liu X; Ren X; Lin S
Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
[TBL] [Abstract][Full Text] [Related]
34. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
Dhandapani S; Singh H; Negm HM; Cohen S; Souweidane MM; Greenfield JP; Anand VK; Schwartz TH
J Neurosurg; 2017 Feb; 126(2):418-430. PubMed ID: 27153172
[TBL] [Abstract][Full Text] [Related]
35. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
36. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
37. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
[TBL] [Abstract][Full Text] [Related]
38. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
Schneider M; Potthoff AL; Keil VC; Güresir Á; Weller J; Borger V; Hamed M; Waha A; Vatter H; Güresir E; Herrlinger U; Schuss P
J Neurooncol; 2019 Oct; 145(1):143-150. PubMed ID: 31485921
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
40. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
